TECOGEN INC.·4

Mar 27, 2:44 PM ET

Lewis Earl 4

4 · TECOGEN INC. · Filed Mar 27, 2026

Research Summary

AI-generated summary of this filing

Updated

TECOGEN (TGEN) Director Lewis Earl Buys 5,000 Shares

What Happened Lewis Earl, a director of TECOGEN INC. (TGEN), reported a purchase of 5,000 common shares on 2026-03-27. The shares were acquired at $2.52 per share for a total transaction value of $12,596. The Form 4 classifies the transaction as a purchase (code P).

Key Details

  • Transaction date and price: 2026-03-27, 5,000 shares at $2.52 per share.
  • Total value: $12,596.
  • Transaction type: Purchase (open market or private purchase as reported).
  • Shares owned after transaction: Not specified in the provided filing.
  • Footnote: F1 indicates the shares were acquired by a trust.
  • Filing timeliness: Report filed on 2026-03-27 (same date as the transaction); no late filing indicated in the provided record.

Context

  • Insider purchases are often viewed as more informative than sales, as they can signal confidence, but they do not prove the insider’s motivation.
  • The acquisition being made by a trust (per footnote) means the shares may be held in a trust account rather than directly in the director’s personal brokerage account; this can affect how the trade is interpreted.

Insider Transaction Report

Form 4
Period: 2026-03-27
Lewis Earl
Director
Transactions
  • Purchase

    Common Stock

    [F1]
    2026-03-27$2.52/sh+5,000$12,5961,011,006 total
Footnotes (1)
  • [F1]Shares acquired by trust
Signature
/s/ Earl R. Lewis|2026-03-27

Documents

1 file
  • 4
    wk-form4_1774637053.xmlPrimary

    FORM 4